When looking for the best stocks to buy and watch, focus on those with rising relative price strength.
One stock that fits that bill is ApellisPharmaceuticals stock, which saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, with an upgrade from 81 to 92.
When looking for the best stocks to buy and watch, keep a close on eye on relative price strength. This exclusive rating from Investor's Business Daily identifies market leadership with a 1 (worst) to 99 (best) score. The rating shows how a stock's price movement over the trailing 52 weeks stacks up against all the other stocks in our database.
History shows that the best stocks often have an RS Rating north of 80 as they launch their biggest price moves.
Looking For The Best Stocks To Buy And Watch? Start Here
Is Apellis Pharmaceuticals Stock A Buy?
Apellis Pharmaceuticals stock is trying to complete a cup without handle with a 60.30 buy point. See if it can break out in heavy volume. Read "Looking For The Next Big Stock Market Winners? Start With These 3 Steps" for more tips.
While sales growth fell last quarter from 769% to -76%, EPS grew 32%, up from 0% in the prior report. The next quarterly numbers are expected on or around Aug. 9.
Apellis Pharmaceuticals stock holds the No. 78 rank among its peers in the Medical-Biomed/Biotech industry group. Amphastar Pharmaceutcls, Corcept Therapeutics and Dynavax Technologies are among the top 5 highly rated stocks within the group. For more industry news, check out "
Biotech And Pharmaceutical Industry And Stock News."
